{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:39:15Z","timestamp":1780403955079,"version":"3.54.1"},"reference-count":126,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1053\/j.semdp.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T09:32:57Z","timestamp":1623835977000},"page":"125-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aggressive Mediastinal Lymphomas"],"prefix":"10.1053","volume":"41","author":[{"given":"Xiaoqiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres E.","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2021.06.010_bib0001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.thorsurg.2010.12.008","article-title":"Correlative anatomy for the mediastinum","volume":"21","author":"Ugalde","year":"2011","journal-title":"Thorac Surg Clin"},{"key":"10.1053\/j.semdp.2021.06.010_bib0002","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/JTO.0000000000000292","article-title":"A modern definition of mediastinal compartments","volume":"9","author":"Carter","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0003","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1378\/chest.128.4.2893","article-title":"Tumors of the mediastinum","volume":"128","author":"Duwe","year":"2005","journal-title":"Chest"},{"key":"10.1053\/j.semdp.2021.06.010_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1634\/theoncologist.5-3-179","article-title":"Primary mediastinal malignancies in children: report of 22 patients and comparison to 197 adults","volume":"5","author":"Temes","year":"2000","journal-title":"Oncologist"},{"key":"10.1053\/j.semdp.2021.06.010_bib0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.semdp.2020.04.005","article-title":"Lymphomas of the Mediastinum and Their Differential Diagnosis","volume":"37","author":"Zhang","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0006","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"10.1053\/j.semdp.2021.06.010_bib0007","series-title":"Bone Marrow Pathology. Vol 2. 4 ed","first-page":"673","article-title":"K R. B- & T-Lymphoblastic Leukemia\/Lymphoma","year":"2020"},{"key":"10.1053\/j.semdp.2021.06.010_bib0008","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.12042","article-title":"The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report","volume":"159","author":"Patel","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0009","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.yexmp.2007.08.012","article-title":"Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias","volume":"83","author":"Suggs","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/AJCPR3N3JMSYLPFG","article-title":"CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T\/myeloid acute leukemia","volume":"137","author":"Hoehn","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0011","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2004-01-0168","article-title":"Activating FLT3 mutations in CD117\/KIT(+) T-cell acute lymphoblastic leukemias","volume":"104","author":"Paietta","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0012","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0013","series-title":"Diagnosis of Blood and Bone Marrow Disorders","author":"Wang","year":"2018"},{"key":"10.1053\/j.semdp.2021.06.010_bib0014","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1309\/2QE3A6EKQ8UYDYRC","article-title":"Precursor T-cell acute lymphoblastic leukemia\/lymphoblastic lymphoma and acute biphenotypic leukemias","volume":"127","author":"Han","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ccr.2004.05.023","article-title":"TAL1\/SCL induces leukemia by inhibiting the transcriptional activity of E47\/HEB","volume":"5","author":"O'Neil","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1053\/j.semdp.2021.06.010_bib0016","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00439-009-0689-7","article-title":"Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood","volume":"126","author":"Novara","year":"2009","journal-title":"Hum Genet"},{"key":"10.1053\/j.semdp.2021.06.010_bib0017","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/sj.leu.2404302","article-title":"Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast","volume":"20","author":"Graux","year":"2006","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2021.06.010_bib0018","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.beha.2010.08.002","article-title":"Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia","volume":"23","author":"Meijerink","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0020","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semdp.2021.06.010_bib0021","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fonc.2020.00273","article-title":"The Physiopathology of T- Cell Acute Lymphoblastic Leukemia","volume":"10","author":"Fattizzo","year":"2020","journal-title":"Focus on Molecular Aspects. Front Oncol."},{"key":"10.1053\/j.semdp.2021.06.010_bib0022","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1053\/j.semdp.2021.06.010_bib0023","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1158\/0008-5472.CAN-06-4381","article-title":"The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling","volume":"67","author":"Malyukova","year":"2007","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2021.06.010_bib0024","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31814b226e","article-title":"t(8;13)-positive bilineal lymphomas: report of 6 cases","volume":"32","author":"Vega","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0025","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","article-title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations","volume":"121","author":"Neumann","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2021.06.010_bib0027","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jclinpath-2018-205399","article-title":"Distinguishing thymoma from T-lymphoblastic leukaemia\/lymphoma: a case-based evaluation","volume":"72","author":"Boddu","year":"2019","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0028","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.humpath.2015.03.007","article-title":"Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease","volume":"46","author":"Kansal","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/PAP.0b013e31828d17ec","article-title":"Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma","volume":"20","author":"Ohgami","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0030","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/PAS.0b013e318264e223","article-title":"TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma","volume":"36","author":"Ohgami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.exphem.2017.04.002","article-title":"Adult T-type lymphoblastic lymphoma: Treatment advances and prognostic indicators","volume":"51","author":"Lepretre","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0032","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","article-title":"Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study","volume":"34","author":"Lepretre","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0033","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/bjh.13545","article-title":"CD33, not early precursor T-cell phenotype, is associated with adverse outcome in adult T-cell acute lymphoblastic leukaemia","volume":"172","author":"Guo","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0034","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.12882","article-title":"Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003","volume":"166","author":"Patrick","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00705408","article-title":"Primary mediastinal clear cell lymphoma of B-cell type","volume":"409","author":"Moller","year":"1986","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0036","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00750725","article-title":"Mediastinal large-cell lymphoma with sclerosis","volume":"412","author":"Scarpa","year":"1987","journal-title":"Genotypic analysis establishes its B nature. Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0037","doi-asserted-by":"crossref","first-page":"17011","DOI":"10.1073\/pnas.1313001110","article-title":"Autoreactive thymic B cells are efficient antigen-presenting cells of cognate self-antigens for T cell negative selection","volume":"110","author":"Perera","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2021.06.010_bib0038","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\"Groupe d'Etude des Lymphomes de l'Adulte\") study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0039","first-page":"1258","article-title":"Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients","volume":"87","author":"Zinzani","year":"2002","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2021.06.010_bib0040","series-title":"Hematopathology","first-page":"437","article-title":"Primary mediastinal (thymic) large B-cell lymphoma","author":"Chan","year":"2017"},{"key":"10.1053\/j.semdp.2021.06.010_bib0041","unstructured":"Duns G, Vigano E, Ennishi D, et\u00a0al. Characterization of DLBCL with a PMBL gene expression signature. 2021 Mar 8;blood."},{"key":"10.1053\/j.semdp.2021.06.010_bib0042","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/PAS.0000000000000473","article-title":"Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling","volume":"39","author":"Yuan","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0043","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2012-06-437210","article-title":"Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene","volume":"121","author":"Saarinen","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0044","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41408-019-0233-5","article-title":"Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma","volume":"9","author":"Wang","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.semdp.2021.06.010_bib0045","series-title":"Tumors of the lymph nodes and spleen","author":"Medeiros LJ","year":"2017"},{"key":"10.1053\/j.semdp.2021.06.010_bib0046","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjh.16331","article-title":"Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma\/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases","volume":"189","author":"Aussedat","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0047","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2011-05-326538","article-title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma","volume":"118","author":"Steidl","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0048","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00000478-200110000-00008","article-title":"Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0049","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63815-1","article-title":"Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins","volume":"162","author":"Pileri","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0050","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1309\/AJCPKUG0UQO0HMDJ","article-title":"Clinicopathologic evaluation of MYC expression in primary mediastinal (thymic) large B-cell lymphoma","volume":"143","author":"Li","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0051","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/PAS.0000000000001154","article-title":"Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2021.06.010_bib0052","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1080\/10428190310001623810","article-title":"Pathobiology of primary mediastinal B-cell lymphoma","volume":"44","author":"Pileri","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2021.06.010_bib0053","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.anndiagpath.2019.02.001","article-title":"American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma","volume":"39","author":"O'Malley","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0054","doi-asserted-by":"crossref","first-page":"E436","DOI":"10.1002\/ajh.24485","article-title":"The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome","volume":"91","author":"Bledsoe","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0055","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0056","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/modpathol.2012.129","article-title":"Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers","volume":"25","author":"Dorfman","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0057","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1309\/AJCP3Q1DHWKCQRWY","article-title":"Surface Light Chain Expression in Primary Mediastinal Large B-Cell Lymphomas by Multiparameter Flow Cytometry","volume":"144","author":"Weinberg","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0058","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cyto.b.21544","article-title":"Evaluation of primary mediastinal large B cell lymphoma by flow cytometry","volume":"94","author":"Cherian","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1053\/j.semdp.2021.06.010_bib0059","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood.V98.9.2762","article-title":"Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma","volume":"98","author":"Leithauser","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0060","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/sj.leu.2404856","article-title":"Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma","volume":"21","author":"Iqbal","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2021.06.010_bib0061","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.2019002067","article-title":"Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade","volume":"134","author":"Chapuy","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0062","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ajcp\/aqw018","article-title":"Primary Mediastinal Large B-Cell Lymphoma With Translocations Involving BCL6 and MYC (Double-Hit Lymphoma)","volume":"145","author":"Campuzano-Zuluaga","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0063","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12308-008-0007-7","article-title":"Primary mediastinal B-cell lymphoma: detection of BCL2 gene rearrangements by PCR analysis and FISH","volume":"1","author":"Dunphy","year":"2008","journal-title":"J Hematop"},{"key":"10.1053\/j.semdp.2021.06.010_bib0064","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"10.1053\/j.semdp.2021.06.010_bib0065","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.2019001126","article-title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","volume":"134","author":"Mottok","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0066","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood-2004-12-4901","article-title":"NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes","volume":"106","author":"Feuerhake","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0067","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2018-05-851154","article-title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","volume":"132","author":"Mottok","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0068","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0069","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/PAS.0000000000001198","article-title":"Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA","volume":"43","author":"Sarkozy","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0070","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2021.06.010_bib0071","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ajh.24082","article-title":"Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort","volume":"90","author":"Evens","year":"2015","journal-title":"American Journal of Hematology"},{"key":"10.1053\/j.semdp.2021.06.010_bib0072","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood-2017-01-764258","article-title":"Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial","volume":"129","author":"Zinzani","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0073","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1200\/JCO.19.01389","article-title":"Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma","volume":"37","author":"Armand","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0074","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/1078-0432.CCR-13-3007","article-title":"Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo","volume":"20","author":"Hao","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2021.06.010_bib0075","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1053\/j.semdp.2021.06.010_bib0076","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/annonc\/9.suppl_5.S31","article-title":"Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma)","volume":"9","author":"Rudiger","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0077","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/modpathol.2011.200","article-title":"The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases","volume":"25","author":"Gualco","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0078","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1200\/JCO.1986.4.3.284","article-title":"The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease","volume":"4","author":"Kant","year":"1986","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1053\/j.semdp.2021.06.010_bib0079","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2020007507","article-title":"Mutational Landscape of Gray Zone Lymphoma","volume":"1137","author":"Sarkozy","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0080","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv"},{"key":"10.1053\/j.semdp.2021.06.010_bib0081","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood-2014-03-564906","article-title":"A prospective study of mediastinal gray-zone lymphoma","volume":"124","author":"Wilson","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0082","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1158\/2643-3230.BCD-20-0009","article-title":"Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma","volume":"1","author":"Pittaluga","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"10.1053\/j.semdp.2021.06.010_bib0083","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/bloodadvances.2020001923","article-title":"Gene expression profiling of gray zone lymphoma","volume":"4","author":"Sarkozy","year":"2020","journal-title":"Blood Adv"},{"key":"10.1053\/j.semdp.2021.06.010_bib0084","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":"Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma","volume":"96","author":"Eberle","year":"2011","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2021.06.010_bib0085","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ajh.24082","article-title":"Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort","volume":"90","author":"Evens","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0086","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0087","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0088","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PAP.0000000000000249","article-title":"Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 1","volume":"26","author":"Pina-Oviedo","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0089","series-title":"Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas","first-page":"274","article-title":"Nodular Sclerosis Hodgkin Lymphoma","author":"Medeiros","year":"2018"},{"key":"10.1053\/j.semdp.2021.06.010_bib0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/PPO.0b013e3181a282d8","article-title":"Clinical manifestations and natural history of Hodgkin's lymphoma","volume":"15","author":"Connors","year":"2009","journal-title":"Cancer J"},{"key":"10.1053\/j.semdp.2021.06.010_bib0091","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0092","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0093","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised","author":"Swerdlow","year":"2017"},{"key":"10.1053\/j.semdp.2021.06.010_bib0094","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/1097-0142(19891015)64:8<1686::AID-CNCR2820640822>3.0.CO;2-I","article-title":"Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients","volume":"64","author":"MacLennan","year":"1989","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2021.06.010_bib0095","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood-2002-05-1548","article-title":"Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages","volume":"101","author":"von Wasielewski","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0096","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/bjh.15614","article-title":"Diagnosis of Hodgkin lymphoma in the modern era","volume":"184","author":"Wang","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0097","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00000478-198607000-00004","article-title":"The \"syncytial variant\" of nodular sclerosing Hodgkin's disease","volume":"10","author":"Strickler","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0098","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2040620716676256","article-title":"Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma","volume":"8","author":"Sethi","year":"2017","journal-title":"Ther Adv Hematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0099","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0344-0338(99)80059-4","article-title":"Thymic Hodgkin's disease\u2013a histological and immunohistochemical study of three cases","volume":"195","author":"Krugmann","year":"1999","journal-title":"Pathol Res Pract"},{"key":"10.1053\/j.semdp.2021.06.010_bib0100","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/modpathol.3800473","article-title":"Rare expression of T-cell markers in classical Hodgkin's lymphoma","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0101","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2006.06.5342","article-title":"Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study","volume":"24","author":"Asano","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0102","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2012-06-439455","article-title":"Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival","volume":"121","author":"Venkataraman","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0103","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.humpath.2017.10.029","article-title":"Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes","volume":"71","author":"Panjwani","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0104","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/ejh.13033","article-title":"Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma","volume":"100","author":"Tanaka","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0105","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1295202","article-title":"HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?","volume":"6","author":"Nijland","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1053\/j.semdp.2021.06.010_bib0106","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin Lymphoma with Reduced beta2M\/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1053\/j.semdp.2021.06.010_bib0107","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0108","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-6413-2-14","article-title":"Is an increase in CD4\/CD8 T-cell ratio in lymph node fine needle aspiration helpful for diagnosing Hodgkin lymphoma? A study of 85 lymph node FNAs with increased CD4\/CD8 ratio","volume":"2","author":"Hernandez","year":"2005","journal-title":"Cytojournal"},{"key":"10.1053\/j.semdp.2021.06.010_bib0109","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/387034","article-title":"Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications","volume":"2011","author":"Roshal","year":"2011","journal-title":"Adv Hematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":"Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","volume":"116","author":"Steidl","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0111","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.10845","article-title":"Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2","volume":"103","author":"Joos","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2021.06.010_bib0112","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma","volume":"99","author":"Martin-Subero","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0113","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.semdp.2021.06.010_bib0114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.seminhematol.2016.05.007","article-title":"Hodgkin lymphoma: Pathology and biology","volume":"53","author":"Mathas","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0115","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0116","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fimmu.2014.00357","article-title":"SOCS Proteins in Macrophage Polarization and Function","volume":"5","author":"Wilson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0117","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.leu.2404036","article-title":"Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma","volume":"20","author":"Melzner","year":"2006","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2021.06.010_bib0118","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2021.06.010_bib0119","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"key":"10.1053\/j.semdp.2021.06.010_bib0120","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1200\/JCO.2005.05.016","article-title":"State-of-the-art therapeutics: Hodgkin's lymphoma","volume":"23","author":"Connors","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0121","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.hoc.2007.07.004","article-title":"New strategies for the treatment of advanced-stage Hodgkin's lymphoma","volume":"21","author":"Diehl","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.semdp.2021.06.010_bib0122","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1200\/EDBK_200679","article-title":"New Treatment Algorithms in Hodgkin Lymphoma: Too Much or Too Little?","author":"Spinner","year":"2018","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"10.1053\/j.semdp.2021.06.010_bib0123","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2014-09-551556","article-title":"How I treat advanced classical Hodgkin lymphoma","volume":"125","author":"Johnson","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2021.06.010_bib0124","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2021.06.010_bib0125","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1016\/S2352-3026(16)30108-9","article-title":"The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study","volume":"3","author":"Agostinelli","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1053\/j.semdp.2021.06.010_bib0126","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T19:50:29Z","timestamp":1717271429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257021000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":126,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0740257021000496"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2021.06.010","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggressive Mediastinal Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}